▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
April 20, 2024

Stocks & Bonds

[STOCK WATCH] Kwangdong Pharmaceutical rises 2.06%

  • PUBLISHED :February 14, 2017 - 14:55
  • UPDATED :February 14, 2017 - 18:23
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[THE INVESTOR] As of Feb. 14 11:55 A.M., Kwangdong Pharmaceutical increased 2.06%, compared with yesterday, to 8,930 won. It had increased 4.2% through the past month. Standard deviation, the risk index for stock price, was 1.6% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Kwangdong Pharmaceutical was the highest, but its volatility within 1 month was the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 2.6. The lowest volatility leads the return-on-risk to its highest level. Moreover, compared with the KOSPI industry, the return-on-risk is much better than the industrial mean, -0.8, and thus the industrial comparison performance was good.

Comparing industry to the market, the KOSPI industry including Kwangdong Pharmaceutical records higher volatility but lower earning rate than Medical Supplies. Even though the earning rate of the industry is negative, the industry was more satisfactory than the market.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.

EDITOR'S PICKS